Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Financial Stress × Endocrine × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Endocrine 1 Breast 1

Conditions

Neuroendocrine Tumors 71 Pituitary Neoplasms 46 Thyroid Cancer, Papillary 28 Multiple Endocrine Neoplasia Type 1 21 Carcinoma, Neuroendocrine 21 Pheochromocytoma 16 Thyroid Neoplasms 13 Paraganglioma 13 Carcinoid Tumor 13 Neoplasm Metastasis 12 Differentiated Thyroid Cancer 12 Adrenocortical Carcinoma 11 Neoplasms 10 Thyroid Carcinoma, Anaplastic 8 Pancreatic Neoplasms 8 Insulinoma 8 Adrenal Gland Neoplasms 8 Pituitary Diseases 6 Lung Neoplasms 6 Acromegaly 6 Stomach Neoplasms 5 Prostatic Neoplasms 5 Prolactinoma 5 Hyperaldosteronism 5 Head and Neck Neoplasms 5 Gastro-enteropancreatic neuroendocrine tumor 5 Carcinoma, Hepatocellular 5 Adrenocortical Adenoma 5 Adenoma, Islet Cell 5 Adenocarcinoma, Follicular 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05334290 2024-03-12

FiReNEN

IRCCS San Raffaele

Financial Stress, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡